Table 3.
Patients | HR-HPV genotype | Age (years) | %CD4+ Tregs | %CD8+ T cells | Sizea | Grade | Stage | Pathology | ER | PR | HER2 |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 16 | 45 | 5.53 | 22 | 2−5 | II | II | IDC | + | + | − |
2 | 16 | 37 | 3.15 | 22 | >5 | II | III | MC | + | + | − |
3 | 16 | 43 | 4.74 | 12.3 | 2−5 | II | II | MC | + | + | − |
4 | 18 | 50 | 3.5 | 33.9 | <2 | II | I | MC | + | + | + |
IDC: invasive duct carcinoma; MC: metaloplastic carcinoma; ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor receptor 2; (+): positive; (−): negative.
Size in centimeters.